Skip to content

A study in patients undergoing laparoscopic surgery to compare the effects of Dexmedetomidine and Magnesium Sulfate on vital signs.

A Comparative study of Adjunct Dexmedetomidine and Magnesium sulphate on Hemodynamic response during Laproscopic Surgery under General Anaesthesia: An Academic Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092504
Enrollment
102
Registered
2025-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: Dose:Loading dose of 1 g/kg followed by maintenance infusion of 0.5 g/kg/hr Frequency: Single administration on the day of surgery. Route of Administration: Intraveno

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients schedule for elective laparoscopic surgery. ASA I and II.

Exclusion criteria

Exclusion criteria: Patient refusal, Patients undergo emergency surgery.

Design outcomes

Primary

MeasureTime frame
Compared to magnesium sulphate, dexmedetomidine demonstrates superior efficacy in stabilizing hemodynamic parameters during pneumoperitoneum in laparoscopic procedures under general anaesthesia.Timepoint: Baseline Before administration of study drug (after IV line placement, before induction). After loading dose 10 minutes after drug administration, before induction. At intubation. 5 minutes after intubation. At creation of pneumoperitoneum. Every 15 minutes intraoperatively. At extubation. Postoperatively at 5,15, minutes in PACU (Post Anaesthesia Care Unit)

Secondary

MeasureTime frame
Less Heart rate, Blood pressure & Mean arterial pressure variability with dexmedetomidine during critical intraoperative periods.Timepoint: Baseline Before administration of study drug (after IV line placement, before induction). After loading dose 10 minutes after drug administration, before induction. At intubation. 5 minutes after intubation. At creation of pneumoperitoneum. Every 15 minutes intraoperatively. At extubation. Postoperatively at 5,15, minutes in PACU (Post Anaesthesia Care Unit)

Countries

India

Contacts

Public ContactDr Ritika Ranjan

Asansol District Hospital

mcmandal80@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026